E-LIB Suche - Ergebnisse für: Greenberg, Peter L.

1

Toward a more patient‐centered drug development process in ..:

Efficace, Fabio ; Buckstein, Rena ; Abel, Gregory A....
HemaSphere. 8 (2024) 5 - p. , 2024

Link: https://doi.org/10.1002/..

2

p53 immunohistochemistry as an ancillary tool for rapid ass..:

Brar, Nivaz ; Lawrence, Lauren ; Fung, Eula...
American Journal of Clinical Pathology. , 2024

Link: https://doi.org/10.1093/..

3

Shared and distinct mechanisms of UBA1 inactivation across ..:

Collins, Jason C ; Magaziner, Samuel J ; English, Maya...
The EMBO Journal. 43 (2024) 10 - p. 1919-1946 , 2024

Link: https://doi.org/10.1038/..

4

The clinical, molecular, and prognostic features of the 202..:

Khanna, Vishesh ; Lu, Rong ; Kumar, Jyoti...
Leukemia Research. 136 (2024) - p. 107433 , 2024

Link: https://doi.org/10.1016/..

5

Myelodysplastic syndromes, thy name is heterogeneity:

Greenberg, Peter L.
British Journal of Haematology. 201 (2023) 3 - p. 381-382 , 2023

Link: https://doi.org/10.1111/..

6

An agenda to advance research in myelodysplastic syndromes:..:

Stahl, Maximilian ; Abdel-Wahab, Omar ; Wei, Andrew H....
Blood Advances. 7 (2023) 12 - p. 2709-2714 , 2023

Link: https://doi.org/10.1182/..

7

3215 – SIRT7 IMPROVES HEMATOPOIESIS IN MYELODYSPLASTIC SYND..:

Wang, Yifei ; Maruichi, Ayane ; Song, zehan..
Experimental Hematology. 124 (2023) - p. S157 , 2023

Link: https://doi.org/10.1016/..

8

Luspatercept for myelodysplastic syndromes/myeloproliferati..:

Komrokji, Rami S. ; Platzbecker, Uwe ; Fenaux, Pierre...
Leukemia. 36 (2022) 5 - p. 1432-1435 , 2022

Link: https://doi.org/10.1038/..

9

Finding consistency in classifications of myeloid neoplasms..:

Zeidan, Amer M. ; Bewersdorf, Jan Philipp ; Buckstein, Rena...
Leukemia. 36 (2022) 12 - p. 2939-2946 , 2022

Link: https://doi.org/10.1038/..

10

Atezolizumab alone or in combination did not demonstrate a ..:

Gerds, Aaron T. ; Scott, Bart L. ; Greenberg, Peter...
Blood Advances. 6 (2022) 4 - p. 1152-1161 , 2022

Link: https://doi.org/10.1182/..

11

Longer-term benefit of luspatercept in transfusion-dependen..:

Zeidan, Amer M. ; Platzbecker, Uwe ; Garcia-Manero, Guillermo...
Blood. 140 (2022) 20 - p. 2170-2174 , 2022

Link: https://doi.org/10.1182/..

12

Epidemiologic evaluation of clinical outcomes in ethnic min..:

Molina, Alfonso ; Xiao, Lan ; Ostrom, Quinn T...
Leukemia Research. 119 (2022) - p. 106907 , 2022

Link: https://doi.org/10.1016/..

13

Phase I First-in-Human Dose Escalation Study of the oral SF..:

Steensma, David P. ; Wermke, Martin ; Klimek, Virginia M....
Leukemia. 35 (2021) 12 - p. 3542-3550 , 2021

Link: https://doi.org/10.1038/..

14

Metchnikoff's legacy: the dysplastic nature of innate immun..:

Greenberg, Peter L.
Haematologica. 107 (2021) 3 - p. 568-569 , 2021

Link: https://doi.org/10.3324/..

15

MDS-171: Effects of Luspatercept on Serum Ferritin in Patie..:

Fenaux, Pierre ; Santini, Valeria ; Mufti, Ghulam J....
Clinical Lymphoma Myeloma and Leukemia. 20 (2020) - p. S317 , 2020

Link: https://doi.org/10.1016/..